Apoptosis as a mechanism of cell death induced by different chemotherapeutic drugs in human leukemic T-lymphocytes

Biochemical Pharmacology

Volumn 51, Issue 10, 1996, Pages 1331-1340

  Da Silva, Cristina P ^a,b   De Oliveira, Catarina R ^a,b   De Lima, Maria Da Conceição P ^a,b  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

anticancer drugs; apoptosis; DNA fragmentation; human T lymphocytes; intracellular calcium; leukemia

Indexed keywords

ANTINEOPLASTIC AGENT; CALCIUM; DAUNORUBICIN; DNA; DNA FRAGMENT; DOXORUBICIN; MERCAPTOPURINE; METHOTREXATE; PREDNISOLONE; VINCRISTINE;

APOPTOSIS; ARTICLE; CALCIUM CELL LEVEL; CELL DEATH; CELL MEMBRANE; CELL PROLIFERATION; CELL SIZE; CELL STRUCTURE; CELL TYPE; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DOSE TIME EFFECT RELATION; HUMAN; HUMAN CELL; LEUKEMIA CELL; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0029947269     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-2952(96)00041-X     Document Type: Article

References (25)

1. Santoro A and Gasparini M, Acute leukemias. In: Handbook of Medical Oncology (Eds. Bonadonna G and Della Cuna GR), pp. 745-764, Masson S.P.A., Milan, 1988.
2. Bonadonna G, Bernardo G, Gianni L and Della Cuna R, Pharmacology, clinical toxicity, dosage and general indications of growth inhibiting compounds. In: Handbook of Medical Oncology (Eds. Bonadonna G and Della Cuna GR), pp. 335-378, Masson S.P.A., Milan, 1988.
3. Jordan MA, Thrower D and Wilson L, Mechanism of inhibition of cell proliferation by Vinca alkaloids. Cancer Res 51: 2212-2222, 1991.
4. Chabner BA, Clendeninn N, Curt GA and Jolivet J, Biochemistry of methotrexate. In: Methotrexate in Cancer Therapy (Eds. Kimura K and Yang YM), pp. 1-37, Academic Press, New York, 1986.
5. Kaufmann SH, Induction of endonucleolytic DNA cleavage in human acute myelogenous leukemia cells by etoposide, camptothecin, and other cytotoxic anticancer drugs: a cautionary note. Cancer Res 49: 5870-5878, 1989.
6. Lear L, Nation RL and Stupans I, Effects of cyclophosphamide and adriamycin on rat hepatic microsomal glucuronidation and lipid peroxidation. Biochem Pharmacol 44: 747-753, 1992.
7. Martin SJ, Green DR and Cotter TG, Dicing with death: dissecting the components of the apoptosis machinery. Trends Biol Sci 19: 26-30, 1994.
8. Collins MKL and Rivas AL, The control of apoptosis in mammalian cells. Trends Biol Sci 18: 307-309, 1993.
9. Sen S and D'incalci M, Apoptosis. Biochemical events and relevance to cancer chemotherapy. FEBS Lett 307: 122-127, 1992.
10. Barry MA, Behnke CA and Eastman A, Activation of programmed cell death (apoptosis) by cisplatin, other anticancer drugs, toxins and hyperthermia. Biochem Pharmacol 40: 2353-2362, 1990.
11. Dive C, Gregory CD, Phipps DL, Evans DL, Milner AE and Wyllie AH, Analysis and discrimination of necrosis and apoptosis (programmed cell death) by multiparameter flow cytometry. Biochim Biophys Acta 1133: 275-285, 1992.
12. Arends MJ, Morris RG and Wyllie AH, Apoptosis. The role of endonuclease. Am J Pathol 136: 593-608, 1990.
13. McConkey DJ, Orrenius S and Jondal M, Cellular signalling in programmed cell death (apoptosis). Immunol Today 11: 120-122, 1990.
14. 2+ and pH. Biochem Biophys Res Commun 186: 782-789, 1992.
15. Old JM, Fetal DNA analysis. In: Human Genetic Diseases: a Practical Approach. (Ed. Davies KE), pp. 1-18, IRL Press, Oxford, 1986.
16. Grynkiewicz G, Ponie M and Tsien RY, A new generation of calcium indicators with greatly improved fluorescent properties. J Biol Chem 260: 3440-3450, 1985.
17. Hotz MA, Del Bino G, Lassota P, Traganos F and Darzynkiewicz Z, Cytostatic and cytotoxic effects of fostriecin on human promyelocytic HL-60 and lymphocytic MOLT-4 leukemic cells. Cancer Res 52: 1530-1535, 1992.
18. Martikainen P, Kyprianou N, Tucker RW and Isaacs JT, Programmed death of nonproliferating androgen-independent prostatic cancer cells. Cancer Res 51: 4693-4700, 1991.
19. Del Bino G and Darzynkiewicz Z, Camptothecin, teniposide, or 4′-(9-acridinylamino)-3-methanesulfon-m-anisidide, but not mitoxantrone or doxorubicin, induces degradation of nuclear DNA in the S phase of HL-60 cells. Cancer Res 51: 1165-1169, 1991.
20. Distelhorst CW, Glucocorticosteroids induce DNA fragmentation in human lymphoid leukemia cells. Blood 72: 1305-1309, 1988.
21. Del Bino G, Skierski JS and Darzynkiewicz Z, Diverse effects of camptothecin, an inhibitor of topoisomerase I, on the cell cycle of lymphocytic (L1210, MOLT-4) and myelogenous (HL-60, KG1) leukemic cells. Cancer Res 50: 5746-5750, 1990.
22. Oberhammer F, Wilson JW, Dive C, Morris ID, Hickman JA, Wakeling AE, Walker PR and Sikorska M, Apoptotic death in epithelial cells: cleavage of DNA to 300 and/or 50 kb fragments prior to or in the absence of internucleosomal fragmentation. EMBO J 12: 3679-3684, 1993.
23. Sorenson CM, Barry MA and Eastman A, Analysis of events associated with cell cycle arrest at G2 phase and cell death induced by cisplatin. J Natl Cancer Inst 82: 749-755, 1990.
24. 2+ are not required to trigger apoptosis in human leukaemia cells. Clin Exp Immunol 87: 465-471, 1992.
25. 2+ in toxic cell killing. Trends Pharmacol Sci 10: 281-285, 1989.